title: Cortical hemosiderin is associated with seizures in patients with newly diagnosed malignant brain tumors.
abstract: Hemorrhage is common in brain tumors. Due to characteristic magnetic field changes induced by hemosiderin it can be detected using susceptibility weighted MRI (SWI). Its relevance to clinical syndromes is unclear. Here we investigated the patterns of intra-tumoral SWI positivity (SWI(pos)) as a surrogate for hemosiderin with regard to the prevalence of epilepsy. We report on 105 patients with newly diagnosed supra-tentorial gliomas and brain metastasis. The following parameters were recorded from pre-operative MRI: (1) SWI(pos) defined as dot-like or fine linear signal changes; (2) allocation of SWI(pos) to tumor compartments (contrast enhancement, central hypointensity, non-enhancing area outside contrast-enhancement); (3) allocation of SWI(pos) to include the cortex, or SWI(pos) in subcortical tumor parts only; (4) tumor size on T2 weighted and gadolinium-enhanced T1 images. 80 tumors (76 %) showed SWI(pos) (4/14 diffuse astrocytoma WHO II, 5/9 anaplastic astrocytoma WHO III, 41/46 glioblastoma WHO IV, 30/36 metastasis). The presence of SWI(pos) depended on tumor size but not on patient's age, medication with antiplatelet drugs or anticoagulation. Seizures occurred in 60 % of patients. Cortical SWI(pos) significantly correlated with seizures in brain metastasis (p = 0.044), and as a trend in glioblastoma (p = 0.062). Cortical SWI(pos) may confer a risk for seizures in patients with newly diagnosed brain metastasis and glioblastoma. Whether development of cortical SWI(pos) induced by treatment or by the natural course of tumors also leads to the new onset of seizures has to be addressed in longitudinal studies in larger patient cohorts.
authors.affiliation: Department of Neurology, Neurooncology, Cantonal Hospital, 5001, Aarau, Switzerland, roelcke@ksa.ch.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Roelcke
authors.forename: Larissa
authors.initials: L
authors.lastname: Boxheimer
authors.forename: Ali Reza
authors.initials: AR
authors.lastname: Fathi
authors.forename: Lucia
authors.initials: L
authors.lastname: Schwyzer
authors.forename: Marcos
authors.initials: M
authors.lastname: Ortega
authors.forename: Jatta
authors.initials: J
authors.lastname: Berberat
authors.forename: Luca
authors.initials: L
authors.lastname: Remonda
mesh_terms: D001932:Brain Neoplasms / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology*; D003287:Contrast Media; D005260:Female; D005500:Follow-Up Studies; D006485:Hemosiderin; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009362:Neoplasm Metastasis; D011379:Prognosis; D012189:Retrospective Studies; D012640:Seizures / Q000209:etiology / Q000378:metabolism / Q000473:pathology*
chemical_list: D003287:Contrast Media; D006485:Hemosiderin
references.citation: J Neurosurg. 1987 Apr;66(4):536-41
references.pmid: 3031239
references.citation: J Neurosurg. 1987 Dec;67(6):852-7
references.pmid: 3316531
references.citation: Acta Radiol. 2011 Feb 1;52(1):115-9
references.pmid: 21498336
references.citation: Acta Neurochir (Wien). 2000;142(1):1-15
references.pmid: 10664370
references.citation: AJNR Am J Neuroradiol. 2009 Aug;30(7):1402-8
references.pmid: 19369602
references.citation: Eur J Radiol. 2010 Jul;75(1):e81-5
references.pmid: 19726149
references.citation: J Neuroimaging. 2011 Oct;21(4):e189-204
references.pmid: 21281380
references.citation: J Clin Oncol. 2010 Apr 10;28(11):1963-72
references.pmid: 20231676
references.citation: J Neurooncol. 2012 May;108(1):109-14
references.pmid: 22311106
references.citation: Lancet Neurol. 2007 May;6(5):421-30
references.pmid: 17434097
references.citation: Exp Neurol. 1998 Sep;153(1):123-7
references.pmid: 9743573
references.citation: J Neurol Neurosurg Psychiatry. 1999 May;66(5):561-8
references.pmid: 10209164
references.citation: Epilepsy Res. 2009 Aug;85(2-3):142-9
references.pmid: 19362806
references.citation: Brain. 2004 Oct;127(Pt 10):2265-75
references.pmid: 15282216
references.citation: Radiology. 1993 Oct;189(1):15-26
references.pmid: 8372185
references.citation: Exp Neurol. 1979 Nov;66(2):277-84
references.pmid: 114406
references.citation: Radiology. 2004 Sep;232(3):874-81
references.pmid: 15284437
references.citation: Neuro Oncol. 2012 Feb;14(2):230-41
references.pmid: 22187341
references.citation: Acta Neurochir (Wien). 1979;49(1-2):35-45
references.pmid: 230705
references.citation: Neurology. 2010 Jul 6;75(1):e2-3
references.pmid: 20603477
references.citation: Acta Neurol Scand. 2007 Dec;116(6):368-73
references.pmid: 17986094